Shining on Major News: China Biologic Products, Inc. (NASDAQ:CBPO), O2Micro International Ltd. (NASDAQ:OIIM), Anika Therapeutics Inc. (NASDAQ:ANIK), StemCells (NASDAQ:STEM), Landstar System (NASDAQ:LSTR)

China Biologic Products, Inc. (NASDAQ:CBPO) belongs to Healthcare sector. Its net profit margin is 36.10% and weekly performance is -3.80%. On last trading day company shares ended up $111.03. China Biologic Products, Inc. (NASDAQ:CBPO) distance from 50-day simple moving average (SMA50) is 2.47%. China Biologic Products, Inc. (NASDAQ:CBPO) was downgraded by Zacks from a “strong-buy” rating to a “hold” rating in a report released on Tuesday.

O2Micro International Ltd. (NASDAQ:OIIM) shares remains unchanged in last trading session and ended the day at $2.51. OIIM Gross Margin is 51.20% and its return on assets is -12.70%. O2Micro International Ltd. (NASDAQ:OIIM) quarterly performance is -2.33%. O2Micro International Ltd. (NASDAQ:OIIM) said that, it will announce its financial results for the second quarter, ended June 30, 2015, on Thursday, July 30, 2015.

Anika Therapeutics Inc. (NASDAQ:ANIK) belongs to Healthcare sector. Its net profit margin is 30.80% and weekly performance is 3.32%. On last trading day company shares ended up $33.33. Anika Therapeutics Inc. (NASDAQ:ANIK) distance from 50-day simple moving average (SMA50) is -1.34%. Anika Therapeutics Inc. (NASDAQ:ANIK) reported positive results from the CINGAL® 13-02 study evaluating the safety of a repeat injection of Cingal for symptomatic relief of osteoarthritis (OA) of the knee. CINGAL combines the Company’s proprietary cross-linked sodium hyaluronate (currently marketed as the single-injection visco supplement MONOVISC®) with an FDA-approved steroid, triamcinolone hexacetonide. Earlier this year, Anika announced positive results from CINGAL 13-01, a randomized, double-blind, placebo-controlled Phase 3 study, which demonstrated the efficacy and safety of a single injection of CINGAL for treatment of pain caused by OA of the knee.

StemCells Inc. (NASDAQ:STEM) shares increased 1.86% in last trading session and ended the day at $0.52. STEM Gross Margin is 90.00% and its return on assets is -183.00%. StemCells Inc. (NASDAQ:STEM) quarterly performance is -48.05%. StemCells Inc. (NASDAQ:STEM) has posted a video of the presentation made by the Company’s vice president of clinical research and chief medical officer Dr. Stephen Huhn, at the ISSCR 2015 Annual Meeting. Held last month in Stockholm, the meeting was attended by approximately 3,000 scientists, clinicians and biotechnology industry professionals from 55 countries, who gathered to share new data and discuss advances within the stem cell field that are currently being explored by peers as potential therapeutic treatments.

On 10 July, Landstar System Inc. (NASDAQ:LSTR) shares increased 0.77% and was closed at $67.80. LSTR EPS growth in last 5 year was 17.50%. Landstar System Inc. (NASDAQ:LSTR) year to date (YTD) performance is -4.93%. Landstar System Inc. (NASDAQ:LSTR) announced it will release its 2015 second quarter results after the market closes on Thursday, July 23, 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *